Medicxi Ventures Management (Jersey) Ltd Long-Term Concentrated

CIK: 0001715579 · Show all filings

Period: Q1 2023 (← Previous) (Next →)

Filing Date: Apr 27, 2023

Total Value ($000): $233,386 (100.0% shares, 0.0% debt)

Holdings (6)

CNTA CENTESSA PHARMACEUTICALS PLC 32.9%

Value ($000) $76,858 Shares 19,963,157 Est. Cost $20.88 Unrealized —

PCVX VAXCYTE INC 23.4%

Value ($000) $54,620 Shares 1,457,300 Est. Cost $32.16 Unrealized +31.9%

— MERUS N V 12.6%

Value ($000) $29,440 Shares 1,600,000 Est. Cost $14.08 Unrealized —

AURA AURA BIOSCIENCES INC 12.1%

Value ($000) $28,210 Shares 3,039,892 Est. Cost $17.87 Unrealized -41.9%

NAMS NEWAMSTERDAM PHARMA COMPANY 11.4%

Value ($000) $26,520 Shares 2,000,000 Est. Cost $9.95 Unrealized +26.8%

PHAT PHATHOM PHARMACEUTICALS INC 7.6%

Value ($000) $17,738 Shares 2,484,274 Est. Cost $22.63 Unrealized -61.2%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CNTA	CENTESSA PHARMACEUTICALS PLC	19,963,157	$76,858	32.9%	$20.88	—	SPONSORED ADS	152309100
PCVX	VAXCYTE INC	1,457,300	$54,620	23.4%	$32.16	+31.9%	COM	92243G108
—	MERUS N V	1,600,000	$29,440	12.6%	$14.08	—	COM	N5749R100
AURA	AURA BIOSCIENCES INC	3,039,892	$28,210	12.1%	$17.87	-41.9%	COM	05153U107
NAMS	NEWAMSTERDAM PHARMA COMPANY	2,000,000	$26,520	11.4%	$9.95	+26.8%	ORDINARY SHARES	N62509109
PHAT	PHATHOM PHARMACEUTICALS INC	2,484,274	$17,738	7.6%	$22.63	-61.2%	COM	71722W107